PF-07258669 | m-entrepreneurship.com

Product Name :
PF-07258669

Search keywords :
MC4R

drugId :
null

Target Vo:
Melanocortin receptor 4

Target Vo Short Name :
MC4R

Moa_Name:
Melanocortin receptor 4 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Pfizer Inc

Active Indication_Name:

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Dnmt3a Rabbit mAb Protocol
Telitacicept custom synthesis
Cytochrome P450 17A1 Antibody (YA786): Cytochrome P450 17A1 Antibody (YA786) is a non-conjugated and Mouse origined monoclonal antibody about 57 kDa, targeting to Cytochrome P450 17A1 (6E1). It can be used for WB assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts